| (1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia FM Marty, S Koo, J Bryar, LR Baden Annals of internal medicine 147 (1), 70-72, 2007 | 107 | 2007 |
| 100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant X Mitre, M Feeley, AC Sherman, SR Walsh, M Cheng, S Kanjilal, VT Ho, ... Open Forum Infectious Diseases 8 (Supplement_1), S63-S63, 2021 | | 2021 |
| 1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT) A Kokogho, MM Aleissa, JBP Chang, SR Walsh, TA Crowell, LR Baden, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 914, 2022 | | 2022 |
| 1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib AE Kusztos, MP Cheng, JN Gustine, TE Dubeau, AE Woolley, ... Open Forum Infectious Diseases 5 (suppl_1), S338-S339, 2018 | | 2018 |
| 1452. Neuroinvasive Bacillus Cereus Infection Amongst Immunocompromised Patients: Epidemiological Investigation of 5 Cases in Patients with Acute Myeloid … JS Little, C Coughlin, CCR Hsieh, M Lanza, W Huang, A Kumar, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1289, 2023 | | 2023 |
| 1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients E Baumrin, MP Cheng, S Kanjilal, N Issa, L Baden Open Forum Infectious Diseases 5 (Suppl 1), S480, 2018 | | 2018 |
| 1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients A Pandit, MP Cheng, A Liakos, N Treister, LR Baden, NC Issa, FM Marty, ... Open Forum Infectious Diseases 5 (Suppl 1), S484, 2018 | | 2018 |
| 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT) AE Kusztos, MP Cheng, TD Bold, VT Ho, BE Glotzbecker, C Hsieh, ... Open Forum Infectious Diseases 5 (suppl_1), S492-S492, 2018 | 1 | 2018 |
| 1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves D Follmann, X Wang, P Gilbert, LR Baden, HM El Sahly, B Essink, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2470, 2023 | 1 | 2023 |
| 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases AR Bass, E Chakravarty, EA Akl, CO Bingham, L Calabrese, LC Cappelli, ... Arthritis care & research 75 (3), 449-464, 2023 | 75 | 2023 |
| 209. Epstein-Barr Virus Surveillance in Lung Transplantation: Post-transplant Lymphoproliferative Disorder and Impact on Survival AJ Kim, HJ Goldberg, T Thaniyavarn, JC Kennedy, A Coppolino, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 286, 2022 | | 2022 |
| 2123. The Impact of Staphylococcus aureus Peri-transplant Cultures on Six-Month Outcomes in Lung Transplantation CE Harris, A Mehta, AJ Kim, HJ Goldberg, HR Mallidi, HR Mallidi, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1744, 2022 | | 2022 |
| 2326. SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions CE Harris, V Vaidya, M Klompas, C Rhee, LR Baden, M Baker Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1948, 2023 | | 2023 |
| 2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies MM Aleissa, S Davey, R Rooks, NE Izaguirre, B Yates, U Kanwal, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1956, 2023 | | 2023 |
| 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients M Powell, AC Sherman, J Klopfer, M Desjardins, CA Cheng, Y Senussi, ... Open Forum Infectious Diseases 8 (Supplement_1), S16-S17, 2021 | | 2021 |
| 2409. Potential candidates for partial oral treatment in patients with endocarditis at a US center MM Pries-Heje, AJ Kim, MRM Joyce, DJ Hartman, EM Connolly, A Itoh, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2029, 2023 | | 2023 |
| 25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients BP Bausk, AC Sherman, M Desjardins, NE Izaguirre, CA Cheng, M Powell, ... Open Forum Infectious Diseases 8 (Supplement_1), S17-S18, 2021 | | 2021 |
| 2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients CE Harris, L Kakoullis, MM Aleissa, EA Haddad, AJ Kim, R Rooks, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2318, 2023 | | 2023 |
| 2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes V Kovac, HJ Goldberg, AJ Kim, MRM Joyce, HR Mallidi, A Coppolino III, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2325, 2023 | | 2023 |
| 36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation E Baumrin, NE Izaguirre, BP Bausk, MM Feeley, CP Bay, VT Ho, NC Issa, ... Open Forum Infectious Diseases 7 (Suppl 1), S42, 2020 | | 2020 |
